PHARMOS CORP
DelistedCIK 713275fmd_13BJJ7NG6D3EZ7YJXFNS53B1TMManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2012, 10 periods
Latest annual · FY2011
Millions- Operating income
- (2)
- Net income
- (2)
Latest quarter · Q3 FY2012
Millions- Operating income
- (0)
- Net income
- (0)
PHARMOS CORP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2011 | FY2010 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.9 million | -$1.4 million | 10-K/A 2012-02-21 · proof | |
| Net income | -$2 million | -$1.5 million | 10-K/A 2012-02-21 · proof | |
| Cash from operating activities | -$1.6 million | -$1.5 million | 10-K/A 2012-02-21 · proof | |
| Total assets | $1.7 million | $3.2 million | -47.9% | 10-K/A 2012-02-21 · proof |
| Total liabilities | $1.4 million | $1.2 million | +16.2% | 10-K/A 2012-02-21 · proof |
| Cash and cash equivalents | $1.5 million | $3.1 million | -51.1% | 10-K/A 2012-02-21 · proof |
- What was PHARMOS CORP's operating income in fiscal 2011?
- PHARMOS CORP reported operating income of -$1.9 million for fiscal 2011 (the year ended Dec 31, 2011), against -$1.4 million the year before. Source: the 10-K/A filed with the SEC on Feb 21, 2012. SEC
- What was PHARMOS CORP's net income in fiscal 2011?
- PHARMOS CORP reported net income of -$2 million for fiscal 2011 (the year ended Dec 31, 2011), against -$1.5 million the year before. Source: the 10-K/A filed with the SEC on Feb 21, 2012. SEC
- What was PHARMOS CORP's cash from operating activities in fiscal 2011?
- PHARMOS CORP reported cash from operating activities of -$1.6 million for fiscal 2011 (the year ended Dec 31, 2011), against -$1.5 million the year before. Source: the 10-K/A filed with the SEC on Feb 21, 2012. SEC
- What are PHARMOS CORP's total assets?
- As of Dec 31, 2011, PHARMOS CORP reported total assets of $1.7 million, against $3.2 million a year earlier (-47.9%). Source: the 10-K/A filed with the SEC on Feb 21, 2012. SEC
- What are PHARMOS CORP's total liabilities?
- As of Dec 31, 2011, PHARMOS CORP reported total liabilities of $1.4 million, against $1.2 million a year earlier (+16.2%). Source: the 10-K/A filed with the SEC on Feb 21, 2012. SEC
- What are PHARMOS CORP's cash and cash equivalents?
- As of Dec 31, 2011, PHARMOS CORP reported cash and cash equivalents of $1.5 million, against $3.1 million a year earlier (-51.1%). Source: the 10-K/A filed with the SEC on Feb 21, 2012. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:713275&period_type=annual&limit=5"Information only, not investment advice.